For mild community-acquired pneumonia in adults with low resistance, which initial outpatient therapy is appropriate?

For mild community-acquired pneumonia in adults with low resistance, which initial outpatient therapy is appropriate?

• A. Macrolide
• B. Doxycycline
• C. Amoxicillin
• D. Ceftriaxone

Answer: (A)

Empiric outpatient treatment for mild CAP in otherwise healthy adults aims to cover both typical bacteria and atypical pathogens. In a setting with low macrolide resistance, starting with a macrolide (such as azithromycin or clarithromycin) provides broad coverage including atypicals like Mycoplasma and Chlamydophila, which commonly cause outpatient CAP, along with Streptococcus pneumoniae. The macrolide also offers convenient oral dosing and good tolerability. Amoxicillin alone covers typical bacteria but misses the atypicals, making it a less reliable first choice for mild CAP. Ceftriaxone is injectable and reserved for more severe disease or inpatient care, not appropriate for a mild outpatient case. Doxycycline is an acceptable alternative, but macrolides are often preferred when resistance is low due to reliable atypical coverage and established outpatient efficacy. Therefore, a macrolide is the appropriate initial outpatient therapy.

Empiric outpatient treatment for mild CAP in otherwise healthy adults aims to cover both typical bacteria and atypical pathogens. In a setting with low macrolide resistance, starting with a macrolide (such as azithromycin or clarithromycin) provides broad coverage including atypicals like Mycoplasma and Chlamydophila, which commonly cause outpatient CAP, along with Streptococcus pneumoniae. The macrolide also offers convenient oral dosing and good tolerability. Amoxicillin alone covers typical bacteria but misses the atypicals, making it a less reliable first choice for mild CAP. Ceftriaxone is injectable and reserved for more severe disease or inpatient care, not appropriate for a mild outpatient case. Doxycycline is an acceptable alternative, but macrolides are often preferred when resistance is low due to reliable atypical coverage and established outpatient efficacy. Therefore, a macrolide is the appropriate initial outpatient therapy.